Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 39Ovarian Neoplasms 29Multiple Myeloma 16Neoplasms 9Recurrence 8Lymphoma 8Fallopian Tube Neoplasms 8Triple Negative Breast Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Hodgkin Disease 7Carcinoma, Ovarian Epithelial 7Lymphoma, Non-Hodgkin 6Sarcoma 5Neoplasm Metastasis 5Burkitt Lymphoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lung Neoplasms 2Liver Neoplasms 2Leukemia 2Leiomyosarcoma 2Kidney Neoplasms 2Endometrial Neoplasms 2Disease Progression 2Vulvar Neoplasms 1Vaginal Neoplasms 1

Interventions

Nivolumab 5olaparib 3Specimen Handling 3Paclitaxel 3durvalumab 2cediranib 2Magnetic Resonance Spectroscopy 2Carboplatin 2Biopsy 2rucaparib 1pazopanib 1pamiparib 1liposomal doxorubicin 1ceralasertib 1capivasertib 1cabozantinib 1apatinib 1Trabectedin 1Ipilimumab 1Immunoglobulin G 1Gemcitabine 1Fluid Therapy 1Disulfides 1Cisplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinosarcoma × liposomal doxorubicin × Clear all
NCT00815945 2017-02-14

Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors

AGO Study Group

Phase 2 Completed
41 enrolled
Sarcoma

Carcinosarcoma, Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡